Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Whitney High

Concepts (386)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Skin Neoplasms
16
2024
806
2.280
Why?
Melanoma
13
2020
765
2.070
Why?
Skin Diseases
10
2013
144
1.840
Why?
Dermatology
5
2013
131
1.200
Why?
Skin Diseases, Vesiculobullous
4
2011
15
1.150
Why?
Immunohistochemistry
14
2020
1712
1.020
Why?
Nephrogenic Fibrosing Dermopathy
6
2012
8
0.930
Why?
Nevus, Pigmented
4
2020
35
0.870
Why?
Gadolinium DTPA
6
2012
70
0.820
Why?
Bedbugs
2
2017
2
0.810
Why?
Contrast Media
9
2012
493
0.730
Why?
Malpractice
3
2013
45
0.710
Why?
Skin
11
2011
701
0.710
Why?
Lupus Erythematosus, Cutaneous
3
2007
7
0.680
Why?
Gadolinium
4
2010
78
0.680
Why?
Dermatitis, Allergic Contact
3
2006
74
0.600
Why?
Psoriasis
3
2013
110
0.540
Why?
Skin Ulcer
1
2018
15
0.540
Why?
Kidney Failure, Chronic
3
2009
589
0.530
Why?
Histiocytosis, Langerhans-Cell
2
2008
36
0.530
Why?
Seminoma
1
2018
20
0.530
Why?
Ectoparasitic Infestations
1
2017
5
0.510
Why?
Dermatitis, Atopic
3
2013
319
0.500
Why?
Neoplasms, Germ Cell and Embryonal
1
2018
76
0.490
Why?
Testicular Neoplasms
1
2018
108
0.480
Why?
Erythema
3
2009
28
0.470
Why?
Scrotum
2
2018
25
0.460
Why?
Nail Diseases
2
2006
8
0.450
Why?
Fibrosis
6
2008
568
0.420
Why?
Neurothekeoma
1
2014
4
0.410
Why?
Defensive Medicine
1
2013
4
0.410
Why?
Telepathology
1
2013
4
0.400
Why?
Licensure
1
2013
16
0.400
Why?
Humans
70
2024
146342
0.400
Why?
Medicare
1
2020
920
0.400
Why?
Diagnostic Errors
2
2012
178
0.390
Why?
Antibodies, Monoclonal
3
2014
1512
0.380
Why?
Lupus Erythematosus, Discoid
2
2015
5
0.340
Why?
Scabies
1
2011
3
0.340
Why?
Elephantiasis
1
2011
3
0.340
Why?
Genital Diseases, Male
1
2011
14
0.340
Why?
Hidradenitis Suppurativa
1
2011
11
0.340
Why?
Ganglion Cysts
1
2011
10
0.340
Why?
Acromioclavicular Joint
1
2011
12
0.330
Why?
Diagnosis, Differential
10
2024
1503
0.330
Why?
Biopsy
7
2021
1075
0.320
Why?
Male
39
2024
73396
0.310
Why?
Piperazines
2
2012
368
0.300
Why?
Biomarkers, Tumor
5
2024
1339
0.300
Why?
Insect Bites and Stings
1
2009
13
0.300
Why?
Cocaine
2
2012
162
0.300
Why?
Spectrometry, Fluorescence
1
2009
165
0.290
Why?
Keratoacanthoma
1
2008
2
0.290
Why?
Keratolytic Agents
1
2008
4
0.290
Why?
Isotretinoin
1
2008
27
0.280
Why?
Pyrimidines
2
2012
532
0.280
Why?
Antineoplastic Agents
3
2010
2219
0.280
Why?
Hypersensitivity, Delayed
1
2008
30
0.270
Why?
Pyroglyphidae
1
2008
18
0.270
Why?
Syphilis
2
2005
39
0.270
Why?
Pathology, Clinical
1
2008
29
0.270
Why?
Sweet Syndrome
1
2007
10
0.270
Why?
Adult
28
2020
41087
0.260
Why?
Scleroderma, Systemic
1
2008
124
0.260
Why?
Kidney Diseases
2
2008
428
0.250
Why?
Female
37
2020
79499
0.250
Why?
Skin Diseases, Infectious
1
2007
14
0.250
Why?
Alopecia
2
2013
33
0.250
Why?
Dermatomyositis
2
2004
24
0.250
Why?
Body Piercing
1
2006
3
0.250
Why?
Antibodies, Antinuclear
2
2004
60
0.250
Why?
Histiocytoma
1
2006
2
0.240
Why?
Hemangiopericytoma
1
2006
5
0.240
Why?
Lymphoma, T-Cell, Cutaneous
1
2007
43
0.240
Why?
Communicable Diseases, Emerging
1
2007
39
0.240
Why?
Epithelioid Cells
1
2006
9
0.240
Why?
Dermatitis, Seborrheic
1
2006
5
0.240
Why?
Granuloma, Pyogenic
1
2006
10
0.240
Why?
Middle Aged
25
2024
36619
0.240
Why?
Neoplastic Syndromes, Hereditary
1
2007
47
0.240
Why?
Exanthema
1
2007
86
0.240
Why?
Titanium
1
2006
74
0.230
Why?
Granuloma
1
2006
96
0.230
Why?
Hyperkeratosis, Epidermolytic
1
2005
4
0.230
Why?
Aged
21
2021
26432
0.230
Why?
Neoplasm Regression, Spontaneous
1
2005
3
0.230
Why?
Genital Diseases, Female
1
2005
31
0.230
Why?
Epstein-Barr Virus Infections
1
2007
102
0.220
Why?
Scalp
1
2005
38
0.220
Why?
Tacrolimus
1
2006
192
0.220
Why?
Allergens
1
2008
390
0.220
Why?
Ossification, Heterotopic
1
2004
18
0.220
Why?
Ear, External
1
2004
22
0.220
Why?
Ear Diseases
1
2004
20
0.210
Why?
Quinazolines
1
2006
267
0.210
Why?
Tuberculosis, Miliary
1
2004
4
0.210
Why?
Tuberculosis, Cutaneous
1
2004
2
0.210
Why?
Antigens, CD20
1
2024
34
0.210
Why?
CD56 Antigen
1
2024
34
0.210
Why?
Telemedicine
1
2013
966
0.200
Why?
Mycosis Fungoides
1
2024
63
0.200
Why?
Fibroma
1
2004
21
0.200
Why?
Agave
1
2003
1
0.200
Why?
Biopsy, Needle
5
2011
183
0.200
Why?
Carcinoma, Squamous Cell
3
2010
628
0.200
Why?
Alendronate
1
2003
14
0.190
Why?
Tumor Virus Infections
1
2003
51
0.190
Why?
Women's Health
1
2005
317
0.190
Why?
Facial Dermatoses
1
2003
17
0.190
Why?
AIDS-Related Opportunistic Infections
1
2004
130
0.190
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
344
0.190
Why?
Vasculitis
1
2003
69
0.190
Why?
Neoplasm Invasiveness
2
2020
504
0.190
Why?
Protein Kinase Inhibitors
2
2012
983
0.190
Why?
Hyperpigmentation
1
2003
26
0.190
Why?
Papillomaviridae
1
2003
113
0.190
Why?
Lymphatic Metastasis
2
2019
335
0.180
Why?
Cicatrix
1
2003
72
0.180
Why?
Antirheumatic Agents
1
2005
309
0.180
Why?
Cheilitis
1
2021
3
0.170
Why?
Pregnancy Outcome
1
2005
503
0.170
Why?
United States
7
2020
16136
0.170
Why?
Prognosis
5
2017
4351
0.170
Why?
Patch Tests
3
2008
61
0.160
Why?
MART-1 Antigen
1
2020
9
0.160
Why?
SOXE Transcription Factors
1
2020
22
0.150
Why?
Genetic Testing
2
2017
492
0.150
Why?
Cannabis
1
2007
521
0.150
Why?
Benzamides
2
2012
226
0.150
Why?
Pulmonary Fibrosis
1
2003
395
0.150
Why?
Pregnancy Complications
1
2005
609
0.150
Why?
Head and Neck Neoplasms
2
2019
563
0.140
Why?
Societies, Medical
1
2003
907
0.140
Why?
Papillomavirus Infections
1
2003
345
0.140
Why?
Aged, 80 and over
8
2015
8391
0.140
Why?
Methotrexate
3
2012
234
0.130
Why?
HIV Infections
2
2004
3215
0.130
Why?
Dermoscopy
2
2017
11
0.130
Why?
Mitogen-Activated Protein Kinases
1
2019
288
0.130
Why?
Retrospective Studies
9
2020
17438
0.130
Why?
Comparative Genomic Hybridization
1
2017
28
0.130
Why?
Gene Regulatory Networks
1
2020
319
0.130
Why?
Lip
2
2021
23
0.130
Why?
Pruritus
2
2009
61
0.130
Why?
STAT3 Transcription Factor
1
2019
214
0.130
Why?
Bites and Stings
1
2017
30
0.120
Why?
Risk Assessment
6
2011
3712
0.120
Why?
Severity of Illness Index
4
2009
2921
0.120
Why?
Tumor Suppressor Proteins
1
2019
315
0.120
Why?
In Situ Hybridization, Fluorescence
1
2017
334
0.120
Why?
Dermatologic Agents
2
2013
69
0.120
Why?
Lichenoid Eruptions
1
2015
2
0.120
Why?
Sampling Studies
2
2007
97
0.110
Why?
Mutation
1
2007
4093
0.110
Why?
Follow-Up Studies
5
2011
5439
0.110
Why?
Renal Dialysis
2
2009
461
0.110
Why?
Child
6
2014
22693
0.100
Why?
Magnetic Resonance Imaging
4
2011
3926
0.100
Why?
Mass Spectrometry
2
2008
729
0.100
Why?
Face
1
2015
177
0.100
Why?
Insurance, Liability
1
2013
8
0.100
Why?
Mohs Surgery
2
2004
30
0.100
Why?
Child, Preschool
4
2014
11913
0.100
Why?
Liability, Legal
1
2013
43
0.100
Why?
Animals
8
2019
38107
0.100
Why?
Gene Expression Profiling
1
2020
1792
0.100
Why?
Photography
1
2013
120
0.090
Why?
Internship and Residency
1
2003
1281
0.090
Why?
Antinematodal Agents
1
2012
7
0.090
Why?
Imatinib Mesylate
2
2012
77
0.090
Why?
Levamisole
1
2012
22
0.090
Why?
Drug Contamination
1
2012
56
0.090
Why?
Immunosuppressive Agents
2
2009
829
0.090
Why?
Granulomatosis with Polyangiitis
1
2012
48
0.090
Why?
Argyria
1
2011
4
0.090
Why?
Fetal Diseases
1
2013
192
0.090
Why?
Granuloma, Foreign-Body
1
2011
8
0.090
Why?
Orphanages
1
2011
2
0.090
Why?
Vietnam
1
2011
27
0.080
Why?
Ethiopia
1
2011
43
0.080
Why?
Foreign-Body Migration
1
2011
32
0.080
Why?
Durapatite
1
2011
36
0.080
Why?
Synovial Fluid
1
2011
69
0.080
Why?
Adoption
1
2011
25
0.080
Why?
Rupture
1
2011
91
0.080
Why?
Cocaine-Related Disorders
1
2012
132
0.080
Why?
Sensitivity and Specificity
3
2020
1998
0.080
Why?
Mucins
1
2011
75
0.080
Why?
Transcription Factors
1
2019
1730
0.080
Why?
Pilot Projects
2
2006
1888
0.080
Why?
Rotator Cuff Injuries
1
2011
79
0.080
Why?
China
1
2011
280
0.080
Why?
Aminolevulinic Acid
1
2010
4
0.080
Why?
Injections, Intralesional
1
2010
34
0.080
Why?
Health Care Costs
1
2013
423
0.080
Why?
Eccrine Glands
1
2009
2
0.080
Why?
Cell Differentiation
1
2018
1982
0.080
Why?
Synchrotrons
1
2009
12
0.080
Why?
Practice Guidelines as Topic
2
2008
1591
0.080
Why?
Iron-Dextran Complex
1
2009
7
0.080
Why?
Guatemala
1
2011
349
0.080
Why?
Photopheresis
1
2009
9
0.080
Why?
Ultraviolet Therapy
1
2009
13
0.080
Why?
Antibodies, Monoclonal, Murine-Derived
1
2010
96
0.080
Why?
Treatment Outcome
4
2012
11821
0.080
Why?
Plasmapheresis
1
2009
24
0.080
Why?
Observation
1
2009
51
0.080
Why?
Arthropod Vectors
1
2009
7
0.070
Why?
Bedding and Linens
1
2009
11
0.070
Why?
Adolescent
5
2014
22557
0.070
Why?
Algorithms
1
2017
1849
0.070
Why?
Naphthoquinones
1
2009
20
0.070
Why?
Hyaluronic Acid
1
2011
227
0.070
Why?
Vitiligo
1
2009
34
0.070
Why?
Rituximab
1
2010
208
0.070
Why?
Fluorouracil
1
2010
231
0.070
Why?
Interleukin-2
1
2010
434
0.070
Why?
Interferon-alpha
1
2010
201
0.070
Why?
Erythropoietin
1
2009
100
0.070
Why?
Histiocytes
1
2008
7
0.070
Why?
Bleomycin
1
2010
255
0.070
Why?
Lymphoma, B-Cell
1
2010
150
0.070
Why?
Histiocytosis
1
2008
9
0.070
Why?
Langerhans Cells
1
2008
10
0.070
Why?
Diabetes Insipidus
1
2008
6
0.070
Why?
Failure to Thrive
1
2008
27
0.070
Why?
Carcinoma, Skin Appendage
1
2007
2
0.070
Why?
Microtubule-Associated Proteins
1
2009
187
0.070
Why?
Prednisone
2
2012
229
0.070
Why?
Antigen-Presenting Cells
1
2008
161
0.070
Why?
Imidazoles
1
2009
245
0.070
Why?
Risk Management
1
2008
81
0.070
Why?
T-Lymphocytes, Helper-Inducer
1
2008
127
0.060
Why?
Epidermis
1
2007
72
0.060
Why?
Keratinocytes
1
2008
190
0.060
Why?
Medical Records
1
2008
193
0.060
Why?
Bone Diseases
1
2008
60
0.060
Why?
Neoplasm Metastasis
1
2010
693
0.060
Why?
Gnathostoma
1
2007
1
0.060
Why?
Pythium
1
2007
1
0.060
Why?
Spirurida Infections
1
2007
1
0.060
Why?
Amoeba
1
2007
5
0.060
Why?
Receptor, Melanocortin, Type 1
1
2007
7
0.060
Why?
Amebiasis
1
2007
6
0.060
Why?
Penicillium
1
2007
8
0.060
Why?
Genes, p16
1
2007
13
0.060
Why?
Electron Probe Microanalysis
1
2006
3
0.060
Why?
Microphthalmia-Associated Transcription Factor
1
2007
14
0.060
Why?
Case-Control Studies
2
2020
3647
0.060
Why?
Skull
1
2008
162
0.060
Why?
Paraffin Embedding
1
2006
33
0.060
Why?
Factor XIIIa
1
2006
6
0.060
Why?
Subcutaneous Tissue
1
2006
26
0.060
Why?
Dermis
1
2006
31
0.060
Why?
Hypopigmentation
1
2006
3
0.060
Why?
Dosage Forms
1
2006
11
0.060
Why?
Combined Modality Therapy
1
2009
1271
0.060
Why?
Microscopy, Electron, Scanning
1
2006
193
0.060
Why?
Neoplasms, Unknown Primary
1
2006
20
0.060
Why?
Pregnancy
3
2013
7230
0.060
Why?
Lysosomes
1
2006
134
0.060
Why?
Organ Specificity
1
2006
307
0.060
Why?
Diabetic Nephropathies
1
2009
320
0.060
Why?
Tissue Distribution
1
2006
334
0.060
Why?
Single-Blind Method
1
2006
313
0.060
Why?
Acidosis
1
2006
105
0.060
Why?
Metals
1
2006
137
0.060
Why?
PTEN Phosphohydrolase
1
2007
166
0.060
Why?
Viscera
1
2005
17
0.060
Why?
Radiography
1
2008
861
0.060
Why?
Pregnancy, Multiple
1
2005
19
0.060
Why?
Remission, Spontaneous
1
2005
39
0.060
Why?
Mitosis
1
2006
195
0.060
Why?
Signal Transduction
1
2019
5246
0.060
Why?
Rare Diseases
1
2005
117
0.050
Why?
Treponema pallidum
1
2004
11
0.050
Why?
Pregnancy Trimester, Third
1
2005
117
0.050
Why?
Urticaria
1
2005
38
0.050
Why?
Proto-Oncogene Proteins B-raf
1
2007
231
0.050
Why?
Cell Transformation, Neoplastic
1
2007
314
0.050
Why?
Infliximab
1
2005
107
0.050
Why?
Foot
1
2005
109
0.050
Why?
Glucocorticoids
2
2012
536
0.050
Why?
Renal Insufficiency
1
2006
173
0.050
Why?
Sclerosis
1
2004
11
0.050
Why?
Hand
1
2005
157
0.050
Why?
Knee Joint
1
2008
453
0.050
Why?
Twins
1
2005
156
0.050
Why?
Infusions, Intravenous
1
2005
432
0.050
Why?
Iron
1
2006
359
0.050
Why?
Staining and Labeling
1
2004
148
0.050
Why?
Nails
1
2003
14
0.050
Why?
Kidney Transplantation
1
2010
735
0.050
Why?
Infant, Newborn
2
2007
6460
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2020
1432
0.050
Why?
Infant
2
2008
10114
0.050
Why?
Chest Pain
1
2004
100
0.050
Why?
Cell Nucleus
1
2006
584
0.050
Why?
Quality of Health Care
1
2008
702
0.050
Why?
Arm
1
2003
111
0.050
Why?
Renal Insufficiency, Chronic
1
2009
640
0.050
Why?
Immunophenotyping
1
2024
324
0.050
Why?
Cell Cycle Proteins
1
2007
630
0.050
Why?
Fatal Outcome
1
2003
302
0.050
Why?
Atrophy
1
2003
199
0.050
Why?
Plant Leaves
1
2003
134
0.050
Why?
Tumor Suppressor Protein p53
1
2006
530
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
846
0.040
Why?
Adrenal Cortex Hormones
1
2005
486
0.040
Why?
Hip Dislocation
1
2002
65
0.040
Why?
Cohort Studies
3
2008
6077
0.040
Why?
Blotting, Western
1
2004
1177
0.040
Why?
Lupus Erythematosus, Systemic
1
2004
241
0.040
Why?
Coronary Disease
1
2004
380
0.040
Why?
Plasma Cells
1
2021
80
0.040
Why?
Hip Joint
1
2002
187
0.040
Why?
Age Factors
1
2008
3347
0.040
Why?
Young Adult
2
2015
14330
0.040
Why?
Osteoporosis
1
2003
240
0.040
Why?
Neoplasm Staging
1
2004
1488
0.040
Why?
Arthroplasty, Replacement, Hip
1
2002
193
0.040
Why?
Rats, Wistar
2
2012
451
0.040
Why?
Respiratory Insufficiency
1
2003
330
0.040
Why?
Reoperation
1
2002
645
0.040
Why?
Kidney
1
2007
1498
0.040
Why?
Risk Factors
3
2009
10921
0.040
Why?
Genotype
1
2003
1879
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2020
974
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
1998
0.030
Why?
Genetic Predisposition to Disease
1
2007
2488
0.030
Why?
Mice, Nude
1
2019
668
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2006
1195
0.030
Why?
Carcinogenesis
1
2019
226
0.030
Why?
Arthritis, Rheumatoid
1
2005
1185
0.030
Why?
T-Lymphocytes
1
2024
2012
0.030
Why?
Phenotype
1
2024
3206
0.030
Why?
Clinical Competence
1
2003
1272
0.030
Why?
Early Detection of Cancer
1
2020
506
0.030
Why?
Minoxidil
1
2013
1
0.030
Why?
Clinical Decision-Making
1
2017
365
0.020
Why?
Retinoids
1
2013
34
0.020
Why?
Acne Vulgaris
1
2013
25
0.020
Why?
Hydroxychloroquine
1
2013
65
0.020
Why?
Lung Neoplasms
1
2006
2675
0.020
Why?
Inflammation
1
2004
2919
0.020
Why?
Rats
2
2012
5586
0.020
Why?
Cross-Sectional Studies
1
2003
5899
0.020
Why?
Injections, Intradermal
1
2011
13
0.020
Why?
Cosmetic Techniques
1
2011
19
0.020
Why?
Emergency Service, Hospital
1
2004
2363
0.020
Why?
Disease Progression
1
2019
2867
0.020
Why?
Cell Line, Tumor
1
2019
3545
0.020
Why?
Microscopy, Electron
1
2011
384
0.020
Why?
Surveys and Questionnaires
1
2003
6073
0.020
Why?
Transcriptome
1
2017
1068
0.020
Why?
Incidence
2
2010
2936
0.020
Why?
Epoetin Alfa
1
2009
9
0.020
Why?
Injections, Intravenous
1
2009
197
0.020
Why?
Drug Therapy, Combination
1
2012
1036
0.020
Why?
Inhibitor of Apoptosis Proteins
1
2009
45
0.020
Why?
Drug Synergism
1
2009
354
0.020
Why?
Keratin-15
1
2007
15
0.020
Why?
Remission Induction
1
2008
308
0.020
Why?
Axilla
1
2006
51
0.010
Why?
Recombinant Proteins
1
2009
1361
0.010
Why?
Antigens, Neoplasm
1
2007
271
0.010
Why?
Proportional Hazards Models
1
2009
1331
0.010
Why?
Dose-Response Relationship, Drug
1
2009
2022
0.010
Why?
Silver Staining
1
2004
16
0.010
Why?
Databases, Factual
1
2010
1493
0.010
Why?
Echocardiography, Stress
1
2004
29
0.010
Why?
Calcium
1
2009
1181
0.010
Why?
Causality
1
2004
128
0.010
Why?
Probability
1
2002
309
0.010
Why?
Age Distribution
1
2002
399
0.010
Why?
Sex Distribution
1
2002
382
0.010
Why?
Gastrointestinal Diseases
1
2004
220
0.010
Why?
Chi-Square Distribution
1
2002
517
0.010
Why?
Mice
1
2019
18297
0.010
Why?
Acute Disease
1
2004
1038
0.010
Why?
Exercise Test
1
2004
637
0.010
Why?
Survival Analysis
1
2004
1378
0.010
Why?
Recurrence
1
2004
1133
0.010
Why?
Joint Instability
1
2002
187
0.010
Why?
Electroencephalography
1
2004
576
0.010
Why?
Hospitalization
1
2004
2475
0.010
Why?
High's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)